Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Channel Therapeutics Corporation Common Stock (NY:CHRO)

1.350 UNCHANGED
Last Price Updated: 8:00 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.350
Bid (Size) 1.180 (1)
Ask (Size) 1.490 (2)
Prev. Close 1.350
Today's Range 1.350 - 1.350
52wk Range 0.4500 - 3.800
Shares Outstanding 3,042,143
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pelthos Therapeutics Launches First At-Home Prescription Gel For Highly Contagious Skin Disease
Pelthos launches Zelsuvmi, the first FDA-approved at-home prescription gel for molluscum, shown to clear lesions in as little as two weeks. 
Via Benzinga
Get insights into the top gainers and losers of Tuesday's pre-market session.
Wondering what's happening in Tuesday's pre-market session? Find an overview in this article. 
Via Chartmill

Performance

YTD
+86.6%
+86.6%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
+8.0%
+8.0%
1 Year
+104.9%
+104.9%

More News

Read More
Why Is Channel Therapeutics Stock Surging On Friday?
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
EXCLUSIVE: Channel Therapeutics Touts Positive Efficacy Results For Eye Treatment Potential In Multiple Preclinical In Vivo Models
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Power Metallic (OTCQB: PNPNF | TSX.V: PNPN): An Undervalued Critical Metals Stock Alongside HTZ, SMX, TGL, CHRO – Trading Under $5
Via AB Newswire
Gold Falls Over 1%; D.R. Horton Posts Downbeat Earnings
Via Benzinga
Channel Therapeutics Stock Soars On Announcement Of Subsidiary’s Merger With Ligand Pharma Units: Retail’s Elated
Via Stocktwits
Dow Falls Over 1%; US Initial Jobless Claims Decline
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Poseida Therapeutics Shares Are Trading Higher By 219%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
From Virtual Investor Conferences
Via GlobeNewswire
CHRO Stock Earnings: Chromocell Therapeutics Reported Results for Q2 2024
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga

Frequently Asked Questions

Is Channel Therapeutics Corporation Common Stock publicly traded?
Yes, Channel Therapeutics Corporation Common Stock is publicly traded.
What exchange does Channel Therapeutics Corporation Common Stock trade on?
Channel Therapeutics Corporation Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Channel Therapeutics Corporation Common Stock?
The ticker symbol for Channel Therapeutics Corporation Common Stock is CHRO on the New York Stock Exchange
What is the current price of Channel Therapeutics Corporation Common Stock?
The current price of Channel Therapeutics Corporation Common Stock is 1.350
When was Channel Therapeutics Corporation Common Stock last traded?
The last trade of Channel Therapeutics Corporation Common Stock was at 07/01/25 08:00 PM ET
What is the market capitalization of Channel Therapeutics Corporation Common Stock?
The market capitalization of Channel Therapeutics Corporation Common Stock is 4.11M
How many shares of Channel Therapeutics Corporation Common Stock are outstanding?
Channel Therapeutics Corporation Common Stock has 4M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.